65,437 trials
Bacterial Pneumonia
Primary: Clinical Response — 227; 228; 53; 52 participants
Human Immunodeficiency Virus Infections
Primary: Percentage of Participants Responding at Week 48 Based on the Food and Drug Administration (FDA) Time to Loss of Virologic Response (TLOVR) Algorithm — 55.3; 51.8…
Ocular Hypertension · Open Angle Glaucoma
Primary: Change in Glaucoma Symptom Scale (GSS)-SYMP-6 Score — 1.7; 3.2 Units on a Scale — p=0.001
Staphylococcal Skin Infection
Primary: Clinical Response — 358; 364; 59; 57 patients
Type 2 Diabetes Mellitus
Primary: Plasma Area Under the Curve (AUC(0 to Infinity)) for Metformin — 7.65; 7.45 μg * hr/mL
Healthy Adult Female Participants · Prevention · Papillomavirus Infection
Primary: Incidence Rate of HPV 6/11/16/18 Related Persistent Infection, Genital Warts, VIN, VaIN, Vulvar Cancer, Vaginal Cancer, Cervical Dysplasia, Cervical AIS, and Cervical…
Myotonic Dystrophy
Primary: The Number of Study Participants Who Safely Tolerated Somatokine — 6; 9 participants
Hypertension
Primary: Reduction From Reference Baseline in Mean Seated Diastolic Blood Pressure at Trough (24-hour Post-dosing) — 9.56; 4.45 mmHg — p=<0.0001
Parkinson's Disease
Primary: Number of Subjects Who Complete the Trial — 17; 16; 16; 17 participants
Postoperative Dental Pain
Primary: Total Pain Relief Score Over the First 6 Hours Post the Initial Day 1 Dose of the Study Medication (TOPAR6) — 5.08; 16.10; 15.73; 15.67 Units on a Scale — p=<0.001
Cataract
Primary: Photostress Recovery Time in Seconds. — 36; 41.46; 24.88 seconds
Squamous Cell Carcinoma of Head and Neck
Primary: Change From Baseline of the Apoptotic Index During Treatment Phase — 6.2; 4.2 Percentage of positive cells — p=.394
Healthy
Primary: Voided Volume — 306 mL
Measles · Mumps · Rubella
Primary: Antibody Response to Varicella for Subjects Who Had Previously Received M-M-R II + VARIVAX - Geometric Mean Titer — 322.2; 209.3 gpELISA units/mL
Rheumatoid Arthritis
Primary: Number of Responders With American College of Rheumatology (ACR) Criteria Improvement of at Least 20%, 50%, and 70% (ACR 20/50/70 Responders) — 12; 7; 5; 15 participants